DR. MICHAEL S BALKIN, MD
Osteopathic Medicine at Main St, Hunt, NY

License number
New York 120257
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
191 EAST Main St, Hunt, NY 11743
Phone
(631) 549-2525
(516) 432-2831 (Fax)

Professional information

Michael S Balkin Photo 1

Dr. Michael S Balkin, Huntington NY - MD (Doctor of Medicine)

Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism
Address:
Michael S Balkin MD
191 E Main St STE 3, Huntington 11743
(631) 549-2525 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 1977, Internal Medicine, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Michael S Balkin MD
191 E Main St STE 3, Huntington 11743
Huntington Hospital
270 Park Ave, Huntington 11743
Education:
Medical School
Mount Sinai School of Medicine
Graduated: 1972
Kings County Hospital Center
Memorial Sloan-Kettering Cancer Center
Mount Sinai Hospital


Michael S Balkin Photo 2

Michael S Balkin, Huntington NY

Specialties:
Endocrinologist
Address:
191 E Main St, Huntington, NY 11743
Education:
Mount Sinai School of Medicine - Doctor of Medicine
Memorial Sloan-Kettering Cancer Center - Fellowship - Endocrinology
Mount Sinai Hospital, The - Fellowship - Endocrinology
Kings County Hospital Center - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Endocrinology and Metabolism (Internal Medicine)


Michael Balkin Photo 3

Oral Transmucosal Delivery Tablet And Method Of Making It

US Patent:
5656284, Aug 12, 1997
Filed:
Apr 24, 1995
Appl. No.:
8/427439
Inventors:
Michael S. Balkin - Huntington NY
International Classification:
A61K 920
US Classification:
424435
Abstract:
A tablet for delivering a pharmaceutical to a human transmucosally is described. The excipient is a gel which is elastic enough for a comfortable fit in the mouth, has suitable gel strength, holds a suitable amount of pharmaceutical and has a structure which allows at least bi-directional delivery of the pharmaceutical to opposed oral mucosa. The tablet is placed between the upper lip mucosa and the opposite gingiva mucosa, and is held in place without any adhesive, by virtue of a snug fit and the elasticity of the tablet. The tablet is made from an organic polymer, e. g. , agarose, and water, glycerol and a pharmaceutical, which may be any of a wide range of pharmaceuticals.